Literature DB >> 31356550

Role of Caspase 1 in Ischemia/Reperfusion Injury of the Myocardium.

Ali Rauf1, Mo Shah, Derek M Yellon, Sean M Davidson.   

Abstract

Acute occlusion of a coronary artery can result in myocardial infarction-a leading cause of premature death. Prompt restoration of blood flow to the myocardium can prevent excessive death of cardiomyocytes and improve clinical outcome. Although the major mechanism of cell death after reperfusion is necrosis, it is now recognized that many other cell death pathways may be involved in ischemia-reperfusion (I/R) injury. Pyroptosis is one such cell death pathway that is caspase-1-dependent and induced in response to cellular insult. The activated caspase-1 protease cleaves and activates specific cellular targets including gasdermin D and the proinflammatory cytokines interleukin-1β and interleukin-18. The N-terminal fragment of gasdermin D forms plasma membrane pores resulting in cytosolic leakage and cell rupture, releasing interleukin-1β and interleukin-18. Evidence suggests that inflammation induced by I/R through the pyroptotic pathway contributes to cardiomyocyte death, excessive scar formation, and poor ventricular remodeling. For this reason, there is growing interest in targeting components of the pyroptotic pathway as a means of reducing I/R injury.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31356550     DOI: 10.1097/FJC.0000000000000694

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  18 in total

1.  Isofraxidin Alleviates Myocardial Infarction Through NLRP3 Inflammasome Inhibition.

Authors:  Guofan Chen; Xiaozheng Song; Dongming Lin; Peng Xu
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

2.  MicroRNA-136-5p protects cardiomyocytes from coronary microembolization through the inhibition of pyroptosis.

Authors:  Ruping Cai; Yuli Xu; Yanling Ren; Shirong He; Jing Zheng; Binghui Kong; Quanzhong Li; Xiheng Yang; Rixin Dai; Riming Wei; Qiang Su
Journal:  Apoptosis       Date:  2022-01-27       Impact factor: 4.677

3.  MMP2 and MMP9 contribute to lung ischemia-reperfusion injury via promoting pyroptosis in mice.

Authors:  Peng Zhou; Nai-Cheng Song; Zhi-Kun Zheng; Yi-Qing Li; Jin-Song Li
Journal:  BMC Pulm Med       Date:  2022-06-15       Impact factor: 3.320

4.  The importance of clinically relevant background therapy in cardioprotective studies.

Authors:  Zhenhe He; Sean M Davidson; Derek M Yellon
Journal:  Basic Res Cardiol       Date:  2020-11-13       Impact factor: 17.165

Review 5.  Pharmacological Protection against Ischemia-Reperfusion Injury by Regulating the Nrf2-Keap1-ARE Signaling Pathway.

Authors:  Bercis Imge Ucar; Gulberk Ucar; Sarmistha Saha; Brigitta Buttari; Elisabetta Profumo; Luciano Saso
Journal:  Antioxidants (Basel)       Date:  2021-05-21

Review 6.  The Role of Extracellular DNA and Histones in Ischaemia-Reperfusion Injury of the Myocardium.

Authors:  Mohammed Shah; Derek M Yellon; Sean M Davidson
Journal:  Cardiovasc Drugs Ther       Date:  2020-02       Impact factor: 3.727

Review 7.  Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury.

Authors:  Sean M Davidson; Adriana Adameová; Lucio Barile; Hector Alejandro Cabrera-Fuentes; Antigone Lazou; Pasquale Pagliaro; Kåre-Olav Stensløkken; David Garcia-Dorado
Journal:  J Cell Mol Med       Date:  2020-03-10       Impact factor: 5.310

Review 8.  Targeting myocardial ischaemic injury in the absence of reperfusion.

Authors:  M V Basalay; D M Yellon; S M Davidson
Journal:  Basic Res Cardiol       Date:  2020-10-14       Impact factor: 17.165

Review 9.  Pyroptosis: A New Regulating Mechanism in Cardiovascular Disease.

Authors:  Nan Ji; Zhongwen Qi; Yueyao Wang; Xiaoya Yang; Zhipeng Yan; Meng Li; Qihui Ge; Junping Zhang
Journal:  J Inflamm Res       Date:  2021-06-22

10.  Si-Miao-Yong-An Decoction Maintains the Cardiac Function and Protects Cardiomyocytes from Myocardial Ischemia and Reperfusion Injury.

Authors:  Wenwen Cui; Shen Xin; Lingjuan Zhu; Mingye Wang; Yuanyuan Hao; Yuqian Zhao; Yang Li; Yunlong Hou
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.